Data as of Apr 17
| -0.17 / -1.97%|
The 3 analysts offering 12-month price forecasts for MEI Pharma Inc have a median target of 16.00, with a high estimate of 20.00 and a low estimate of 12.00. The median estimate represents a +88.68% increase from the last price of 8.48.
The current consensus among 4 polled investment analysts is to Buy stock in MEI Pharma Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.